ATAI Life Sciences
ATAI
ATAI
93 hedge funds and large institutions have $63.9M invested in ATAI Life Sciences in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 7 closing their positions.
Holders
93
Holders Change
+14
Holders Change %
+17.72%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
23
Increased
19
Reduced
22
Closed
7
Calls
$461K
Puts
$675K
Net Calls
-$214K
Net Calls Change
-$1.1M
Top Buyers
| 1 |
1
Adage Capital Partners
Boston,
Massachusetts
|
$11.9M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$16.9M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$2.58M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$613K |
| 5 |
5
Goldman Sachs
New York
|
$762K |
Top Sellers
| 1 |
DKCM
1
Davidson Kempner Capital Management
New York
|
$0 |
| 2 |
BC
2
BIT Capital
Berlin,
Germany
|
$50.8K |
| 3 |
3
BlackRock
New York
|
$9.64K |
| 4 |
4
D.E. Shaw & Co
New York
|
$1.52M |
| 5 |
5
Citigroup
New York
|
$10.4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
|
GFI
102
Global Frontier Investments
Charleston,
South Carolina
| – | – | – | – |
|